Depression and Anxiety Trial, Recruiting NCT07185451 Sponsor: First Affiliated Hospital of Chongqing Medical University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07185451
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 12 and 18 years.
  • People who have been diagnosed with a current depressive episode according to standard diagnostic guidelines (DSM-5), confirmed through a structured interview called the K-SADS-PL.
  • People whose depression scores at least 40 on a standard rating scale called the CDRS-R at the start of the trial.
  • People who have been on a stable psychiatric medication regimen for at least 4 weeks before joining, and who are willing to keep taking the same medications throughout the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a psychiatric diagnosis other than an anxiety disorder alongside their depression.
  • People whose depression includes psychotic features (such as hallucinations or delusions).
  • People who score above 13 on a rating scale used to measure signs of mania (called the YMRS).
  • People with a history of neurological conditions (such as epilepsy or traumatic brain injury) or serious physical health conditions (such as thyroid disease, lupus, diabetes, or significant problems with the liver, kidneys, or lungs, or a history of major physical trauma).
  • People who have previously been treated with electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), or any other similar brain stimulation therapies.
  • People who are currently taking anti-epileptic medications or high doses of benzodiazepines (a type of sedative medication).
  • People with a history of alcohol or drug misuse or dependence.
  • People who are pregnant or breastfeeding.
  • People for whom an MRI scan would not be safe or suitable (confirm with trial site).
  • People who are currently considered to be at high risk of suicide.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Kids Helpline — 24/7, free and private for anyone aged 5 to 25: 1800 55 1800
  • headspace — mental health support for 12 to 25 year olds: headspace.org.au
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Phone: 15823996993

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
First Affiliated Hospital of Chongqing Medical University
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
30 March 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in CDRS-R (Children's Depression Rating Scale) scores from baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov